Mutational profile of primary dermal melanoma: A case series - 14/11/16
Doi : 10.1016/j.jaad.2016.08.028
Bryan K. Sun, MD, PhD a, ⁎ 
, Hua Wang, MS a, Jinah Kim, MD, PhD a, Jer-Kang Chen, PhD b, Lihyun Sun, PhD b, Yilin Zhang, PhD b, ⁎ , Susan M. Swetter, MD a, c
, Hua Wang, MS a, Jinah Kim, MD, PhD a, Jer-Kang Chen, PhD b, Lihyun Sun, PhD b, Yilin Zhang, PhD b, ⁎ , Susan M. Swetter, MD a, c a Department of Dermatology, Stanford University School of Medicine, Stanford, California
b Elim Biopharmaceuticals, Hayward, California
c Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California
∗Correspondence to: Bryan K. Sun, MD, PhD, Department of Dermatology, University of California- San Diego, 9500 Gilman Drive MC 0869, La Jolla, CA 92093-0869Department of DermatologyUniversity of California- San Diego9500 Gilman Drive MC 0869La JollaCA92093-0869∗∗Yilin Zhang, PhD, Elim Biopharmaceuticals, 25495 Whitesell St, Hayward, CA 94545Elim Biopharmaceuticals25495 Whitesell StHaywardCA94545
| Supported by a Skin Cancer Foundation grant to Bryan K. Sun. |
|
| RightOn Sequencing is a proprietary reagent of Elim Biopharmaceuticals. |
© 2016
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 75 - N° 6
P. 1263 - décembre 2016 Retour au numéro
Article précédent
- A cross-sectional study of skin cancer patients' willingness and ability to take biopsy “selfies” to aid in later treatment
- Kathleen M. Casamiquela, Patrick C. Carr, William H. Black
- Increased cutaneous stimulation is required for C-fiber sensory perception in alopecia areata: A double-blind study
- Ronda S. Farah, Rina S. Farah, Ana Carina Junqueira Bertin, Hongfei Guo, Marna E. Ericson, Maria K. Hordinsky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?